You just read:

SELLAS Life Sciences to Present Phase 2 Clinical Results for WT1 Cancer Vaccine at the 2016 ASCO Annual Meeting and the 13th International Conference of the International Mesothelioma Interest Group (iMig)

News provided by

SELLAS Life Sciences Group

Apr 01, 2016, 13:00 ET